NewBridge Pharmaceuticals
Newbridge's core therapeutic areas of focus are oncology, cardiology, neurology, and rare diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€175—262m (Dealroom.co estimates Mar 2013.)
Ajman Ajman Emirate (HQ)
Authorizing premium user...